Barclays initiated coverage of Legence (LGN) with an Equal Weight rating and $34 price target The firm is positive on the company’s data center and life science growth prospects, but says expectations on its future growth are high.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGN: